GRFS

Grifols, S.A.

7.09 USD
-0.42 (-5.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Grifols, S.A. stock is down -11.82% since 30 days ago. The next earnings date is Jul 27, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 6 PUTs, 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jan 18:12 16 Feb, 2024 7.50 PUT 384 2757
23 Jan 20:17 15 Mar, 2024 7.50 PUT 443 9
05 Feb 20:55 16 Feb, 2024 10.00 PUT 174 3160
12 Feb 17:34 20 Dec, 2024 10.00 CALL 185 620
22 Feb 15:12 20 Dec, 2024 10.00 CALL 134 2797
22 Feb 18:10 16 Aug, 2024 7.50 CALL 175 54
29 Feb 15:08 19 Apr, 2024 6.00 PUT 1000 1
29 Feb 16:36 16 Aug, 2024 6.00 PUT 310 4
29 Feb 19:11 19 Apr, 2024 8.00 CALL 500 0
01 Mar 15:14 15 Mar, 2024 6.00 PUT 777 1642

About Grifols, S.A.

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Company offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins.